This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.Need a new registration confirmation email? Click here

Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) (SWX:OXBT) today announced that the Company plans to report its year-end and fourth quarter fiscal year 2011 financial results on Form 10-K on Thursday, July 14, 2011. Oxygen’s Chairman and CEO Chris Stern and Chief Financial Officer Michael Jebsen will host a conference call and live webcast to discuss the results on Friday, July 15, 2011, at 11 a.m. EDT.

To access the live teleconference dial (800) 688-0836 (U.S. and Canada) or (617) 614-4072 (international). The participant pass code is 26134845. A live webcast will be available on our web site
http://www.oxybiomed.com/investors.htm

A replay of the webcast will be available on the Oxygen website, or by phone for a limited time. To access the replay by phone, call (888) 286-8010 (U.S. and Canada) or (617) 801-6888 (international). The pass code for the replay is 98577075.

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is developing intravenous and topical medical products that deliver oxygen to tissues in the body. Currently, the company is focused on traumatic brain injury, wound healing, dermatologic indications and decompression sickness. In addition, the Company markets and sells its DERMACYTE
® line of oxygen-rich skin care products.